The Source Blog
Trends in Price and Quality Transparency
All Payer Claims Databases (APCD)
For more on APCD’s, check out our Legislative Topics: All Payer Claims Databases overview on Medium.
- Key:
- Implementing APCD
- Investigating APCD
Pharmaceutical Price Transparency Legislation
For more on this legislation, refer to our Issue Brief on The Source Blog and the NASHP Center for Rx Pricing.
- Key:
- Price Transparency Legislation
Recent Action in Price and Quality Transparency
SB 2 (see companion bill HB 1010) – Arkansas
Introduced: 2018 Status: Enacted
THE ARKANSAS PHARMACY BENEFITS MANAGER LICENSURE ACT: Beginning September 2018, this law requires pharmacy benefits managers to become licensed, file an annual statement about its sales and contracts within the state, and provide a report …
HB 1010 (see companion bill SB 2) – Arkansas
Introduced: 2018 Status: Enacted
THE ARKANSAS PHARMACY BENEFITS MANAGER LICENSURE ACT: Beginning September 2018, this law requires pharmacy benefits managers to become licensed, file an annual statement about its sales and contracts within the state, and provide a report …
SB 1166 – Pennsylvania
Introduced: 2018 Status: Inactive / Dead
Amends the Pharmacy Audit Integrity and Transparency Act of 2016, adding provisions relating to public contracting for pharmacy benefits management. No public pharmacy benefits management contract may prohibit a pharmacy from disclosing lower-cost prescription drug …
HB 2211 – Pennsylvania
Introduced: 2018 Status: Inactive / Dead
CONSUMER PRESCRIPTION DRUG PRICING DISCLOSURE ACT. A pharmacy or pharmacist shall have the right to provide a covered individual with all available information concerning the cost of a prescription drug, including, but not limited to, …
HB 436 – Louisiana
Introduced: 2018 Status: Enacted
PROVIDES RELATIVE TO THE REGULATION OF PHARMACY BENEFIT MANAGERS: Prohibits PBM network contract provisions that prohibit pharmacist from disclosing any relevant information to a consumer, including but not limited to the cost of the prescription …
Next | See all Legislation Records
Introduced: 2018 Status: Enacted
THE ARKANSAS PHARMACY BENEFITS MANAGER LICENSURE ACT: Beginning September 2018, this law requires pharmacy benefits managers to become licensed, file an annual statement about its sales and contracts within the state, and provide a report …
HB 1010 (see companion bill SB 2) – Arkansas
Introduced: 2018 Status: Enacted
THE ARKANSAS PHARMACY BENEFITS MANAGER LICENSURE ACT: Beginning September 2018, this law requires pharmacy benefits managers to become licensed, file an annual statement about its sales and contracts within the state, and provide a report …
SB 1166 – Pennsylvania
Introduced: 2018 Status: Inactive / Dead
Amends the Pharmacy Audit Integrity and Transparency Act of 2016, adding provisions relating to public contracting for pharmacy benefits management. No public pharmacy benefits management contract may prohibit a pharmacy from disclosing lower-cost prescription drug …
HB 2211 – Pennsylvania
Introduced: 2018 Status: Inactive / Dead
CONSUMER PRESCRIPTION DRUG PRICING DISCLOSURE ACT. A pharmacy or pharmacist shall have the right to provide a covered individual with all available information concerning the cost of a prescription drug, including, but not limited to, …
HB 436 – Louisiana
Introduced: 2018 Status: Enacted
PROVIDES RELATIVE TO THE REGULATION OF PHARMACY BENEFIT MANAGERS: Prohibits PBM network contract provisions that prohibit pharmacist from disclosing any relevant information to a consumer, including but not limited to the cost of the prescription …
Next | See all Legislation Records
Pharmaceutical Care Management v. Rutledge – Arkansas
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. Brown – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
See all Litigation Records
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. Brown – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
See all Litigation Records
News & Opinions
Articles & Reports
U.S. Department of Health and Human Services December 4, 2018
Health Affairs December 3, 2018
Health Affairs Blog October 30, 2018
Health Affairs Blog September 25, 2018
Health Affairs December 3, 2018
Health Affairs Blog October 30, 2018
Health Affairs Blog September 25, 2018